Akebia Therapeutics, Inc. AKBA 38.61
Health Care · NASDAQ · Data as of 2026-08-05
Akebia Therapeutics, Inc. (AKBA) has delivered +30.1% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1504 of 1968 stocks overall and #187 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
38.61
Overall Rank
#1504 / 1968
Sector Rank
#187 / 260
Revenue CAGR
+30.1%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio